IORT for early-stage, low-risk breast cancer: Outcomes from a prospective, observational study
Local recurrence rates were low amongst all groups. Superior control outcomes could be obtained by applying more restrictive criteria than the TARGIT A trial. Longer follow-up is needed to confirm our findings.
Authors
- Miriam Moreno-Manzanaro
- María Espinosa-Calvo
- Amalia Palacios (ORCID: https://orcid.org/0000-0002-7575-227X)
- Sonia García-Cabezas
- Gustavo R. Sarria (ORCID: https://orcid.org/0000-0002-5929-7270)
- Pilar Rioja‐Torres (ORCID: https://orcid.org/0009-0009-7288-4304)
- Ángel Calvo-Tudela
- Fátima Ginés-Santiago
- Sara Romero-Martín (ORCID: https://orcid.org/0000-0003-3459-9050)
- Juan Adrián Camús-Martínez
Institutions
- University Hospital Bonn (DE)
- Hospital Universitario Reina Sofía (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-06-22
- DOI
- https://doi.org/10.1016/j.ctro.2025.100998
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00